NOT-AA-22-008: Notice of NIAAA's Participation in RFA-DA-22-047, "HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional)"

Notice of NIAAA's Participation in RFA-DA-22-047, "HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional)"

Notice Number:

NOT-AA-22-008

Key Dates

Release Date:

January 25, 2022

Related Announcements

RFA-DA-22-047 - HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional)

Issued by

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Purpose

This Notice informs potential applicants that the National Institute on Alcohol Abuse and Alcoholism (NIAAA) is participating, effective immediately, in Funding Opportunity Announcement (FOA) RFA-DA-22-047, HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional)

The following information has been added in indicated sections below of RFA-DA-22-047, to reflect NIAAA's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Assistance Listing Number(s)

93.273

Part 2. Full Text of Announcement

Section VII. Agency Contacts

Scientific/Research Contact(s)

Laura E. Kwako, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-451-8507
Email: [email protected]

Financial/Grants Management Contact(s)

Judy Fox
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-4707
Email: [email protected]

Inquiries

Please direct all inquiries to:

Abraham P. Bautista, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-9737
Email: [email protected]